Pelvic Regional Control With 25 Gy in 5 Fractions in Stereotactic Radiation Therapy for High-Risk Prostate Cancer: Pooled Prospective Outcomes From the SHARP Consortium

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis et al. · The Lancet · 2020 · 2K citations

Medicine, Nuclear Medicine, Oncology +17

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Anders Widmark, Adalsteinn Gunnlaugsson, L. Beckman et al. · The Lancet · 2019 · 871 citations

Medicine, Radiation Oncology, Urology +16

Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy

Krzysztof Bujko, Marek P. Nowacki, Anna Nasierowska‐Guttmejer et al. · Radiotherapy and Oncology · 2004 · 506 citations

Medicine, Radiation Oncology, Surgery +15

RTOG GU Radiation Oncology Specialists Reach Consensus on Pelvic Lymph Node Volumes for High-Risk Prostate Cancer

C.A. Lawton, Jeff M. Michalski, Issam El Naqa et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 413 citations · Full text

Medicine, Radiation Oncology, Urology +14

Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial

Vedang Murthy, Priyamvada Maitre, Sadhana Kannan et al. · Journal of Clinical Oncology · 2021 · 327 citations

Medicine, Oncology, Urology +17